About Contact Us Careers

Lab Evolved Enzymes Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3914
Published Date: Aug 22, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Lab Evolved Enzymes Landscape

AB Enzymes GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
121 Bio, LLC
Aeglea BioTherapeutics, Inc.
AM-Pharma B.V.
Alphazyme LLC
APEIRON Biologics AG
Aronora, Inc.
Arzeda
Aralez Bio
BIO-CAT

Browse Key Market Insights with Data Illustration:

Lab Evolved Enzymes Market Size, Growth Forecast 2036

In the News

December 2021- Aeglea BioTherapeutics announced achievement of primary endpoint in Phase 3 study of Pegzilarginase in patients with Arginase 1 deficiency.
July 2021- Unilever declared a multi-year partnership with Arzeda to discover new enzymes that will aim at the discovery of new enzymes designed by computer to transform the sustainability and performance of cleaning and laundry products.

Author Credits: Rajrani Baghel

Report ID: 3914
Published Date: Aug 22, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Lab Evolved Enzymes Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2024-2036.

The market growth is driven by growing emphasis towards renewable energy, and increasing demand for natural substitute for synthetic chemicals.

North America industry is likely to dominate majority revenue share by 2036, due to development of novel and superior performing products in the region.

The major players in the market are AB Enzymes GmbH, 121 Bio, LLC, Aeglea BioTherapeutics, Inc., AM-Pharma B.V., Alphazyme LLC, and others.

Inquiry Before Buying Request Free Sample